烧伤中心ICU中万古霉素持续输注与间歇输注的比较
该回顾性队列研究纳入烧伤面积≥10%且接受静脉万古霉素≥48小时的患者,比较持续输注与间歇输注。持续输注组达到目标血药浓度的比例更高(73.3% vs 26.7%,p=0.0003),达标时间更短(3.90天 vs 5.22天,p=0.0393),肾毒性发生率更低(23.3% vs 53.8%)。
要点
- 持续输注万古霉素达标比例更高、达标更快
- 持续输注组肾毒性发生率低于间歇输注组
- 目标浓度:持续输注17-22 mg/L,间歇输注谷浓度15-20 mg/L
核心结论
- 持续输注万古霉素与更快速达到目标血药浓度和更低肾毒性发生率相关。
研究设计与样本
- 回顾性队列研究,在大型学术医学中心及区域烧伤中心开展。
- 纳入烧伤面积≥10%总休表面积且接受静脉万古霉素≥48小时、至少1次血药浓度记录的患者。
主要发现
- 持续输注组73.3%的患者达到目标血药浓度,间歇输注组为26.7%(p=0.0003)。
- 持续输注组达标时间为3.90天,间歇输注组为5.22天(p=0.0393)。
- 肾毒性发生率持续输注组为23.3%,间歇输注组为53.8%。
关键数值与推荐
- 持续输注目标稳态血药浓度为17-22 mg/L。
- 间歇输注目标稳态谷浓度为15-20 mg/L。
临床怎么用
- 在烧伤ICU患者中,可考虑持续输注万古霉素以更快达标并降低肾毒性风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vancomycin is a common and critical drug for empiric antimicrobial therapy in the infected burn patient. However, profound physiologic changes may impede the clinical effectiveness and amplify the potential nephrotoxicity of vancomycin. METHODS: This was a retrospective cohort study at a large academic medical center and regional burn center. Patients with ≥10% total body surface area burn that received intravenous vancomycin were considered for study inclusion. Patients were assigned to the intermittent infusion or continuous infusion cohort if they received vancomycin for ≥48 h with ≥1 documented vancomycin serum concentration. The target steady state drug level for continuous infusion was 17-22 mg/L. The target steady state trough drug level for intermittent infusion was 15-20 mg/L. The primary efficacy and safety outcomes were time to therapeutic drug level and nephrotoxicity respectively. RESULTS: Thirty continuous infusion subjects with 88 plasma drug levels and thirty intermittent infusion subjects with 80 plasma drug levels were analyzed within the study period. There was a significant difference in the number of subjects that achieved a plasma vancomycin level within the target range during the course of therapy (73.3% for continuous infusion vs. 26.7% for intermittent infusion, p = 0.0003). The time to therapeutic level was 3.90 days for continuous infusion and 5.22 days for intermittent infusion (p = 0.0393). Nephrotoxicity occurred less frequently in the continuous infusion cohort (23.3% vs. 53.8%). CONCLUSION: Continuous infusion vancomycin was associated with more rapid attainment of target levels and a lower rate of nephrotoxicity.
引用
- Schlobohm CJ, Zhu E, Duby JJ, et al. Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit. Burns. 2021. PMID: 34538672. doi:10.1016/j.burns.2021.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。